Perilesional GM-CSF therapy of a chronic leg ulcer in a patient with common variable immunodeficiency [1]

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 2, 2005, Pages 460-462

  Hatab, Ammar Z ^a   McDanel, Deanna ^b   Ballas, Zuhair K ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AGED; ASTHMA; BACTERIUM CULTURE; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE COURSE; DOSE RESPONSE; HEALTH CARE COST; HUMAN; LEG ULCER; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYOSITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN GRAFT; TENSILE STRENGTH; WOUND HEALING IMPAIRMENT;

AGED; CHRONIC DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEG ULCER; MALE;

EID: 23244435429     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.04.008     Document Type: Letter

References (9)

1. R.W. Groves, and J.A. Schmidt-Lucke Recombinant human GM-CSF in the treatment of poorly healing wounds Adv Skin Wound Care 13 2000 107 112
2. G.E. Hancock, G. Kaplan, and Z.A. Cohn Keratinocyte growth regulation by the products of immune cells J Exp Med 168 1988 1395 1402
3. G. Gabbiani Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis Pathol Res Pract 190 1994 851 853
4. R.W. Jyung, L. Wu, G.F. Pierce, and T.A. Mustoe Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing Surgery 115 1994 325 334
5. S.G. Reed, C.F. Nathan, D.L. Pihl, P. Rodricks, K. Shanebeck, and P.J. Conlon Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide: comparison with interferon gamma J Exp Med 166 1987 1734 1746
6. W.Y. Weiser, A. Van Niel, S.C. Clark, J.R. David, and H.G. Remold Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages J Exp Med 166 1987 1436 1446
7. M. Robson, A. Kucukcelebi, S.S. Carp, P.G. Hayward, P.S. Hui, and W.T. Cowan Effects of granulocyte-macrophage colony-stimulating factor on wound contraction Eur J Clin Microbiol Infect Dis 13 suppl 2 1994 S41 S46
8. R.M. Da Costa, F.M. Ribeiro Jesus, C. Aniceto, and M. Mendes Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers Wound Repair Regen 7 1999 17 25
9. F.H. Siddiqui, J.J. Biundo Jr., C. Moore, M.L. Ermitano, A.P. Ortigas, and F. DeFrancesch Recombinant granulocyte macrophage colony stimulating factor (rhu-GM-CSF) in the treatment of extensive leg ulcers: a case report Surgery 127 2000 589 592